Strategic Collaboration Agreement Signed Between Nojine Zist Pharmed and Pasteur Institute of Iran

In an effort to deepen synergy between applied pharmaceutical manufacturing and national academic research institutions, Nojine Zist Pharmed and the Pasteur Institute of Iran signed a comprehensive strategic collaboration memorandum.

The agreement encompasses shared initiatives in targeted immunotherapy formulations, hyperimmune plasma isolation techniques, and preclinical efficacy assessments. Under this joint framework, multidisciplinary research taskforces from both organizations will collaborate on advanced polyclonal antibody engineering and novel protein stabilization approaches.

Both parties affirmed that connecting academic research capabilities with Nojine’s high-capacity aseptic manufacturing infrastructure will accelerate the translation of molecular discoveries into life-saving therapeutic solutions for patients with rare immune deficiencies.